Skip to main content
Journal of Dental Sciences logoLink to Journal of Dental Sciences
. 2020 May 1;16(1):304–310. doi: 10.1016/j.jds.2020.04.003

Long-term follow-up of oral epithelial dysplasia: A hospital based cross-sectional study

Mohamed Abdullah Jaber a,, Essra Mohamed Elameen b
PMCID: PMC7770253  PMID: 33384813

Abstract

Background/purpose

Oral epithelial dysplasia (OED) is characterized histopathologically by cellular and morphological changes that remain the single most important factor predicting risk for subsequent development of invasive neoplasia. Hence the aims of the present study were to determine the rate of malignant change of OED in a group of patients followed-up for a number of years, and hence determine factors likely to influence this malignant change, and to describe the clinical characteristics of patients who developed recurrence of OED and second dysplastic lesions.

Materials and methods

This is hospital based cross-sectional study of all biopsy reports with histologically confirmed OED between 2012 and 2018 were retrospectivelly reviewed.

Results

A total of 359 patients with histologically confirmed OED were reviewed, twenty (5.5%) of the 359 patients developed an invasive squamous cell carcinoma (SCC) of the oral mucosa over a period of 2 to 274 months with mean transformation time of 3.3 years.

Conclusion

The high risk of malignant transformation of OED seems to be related to patients older than 50 years when lesions were on the floor of mouth with severe dysplastic changes.

Keywords: Epithelial dysplasia, Oral, Potentially malignant lesions, Squamous cell carcinoma

Introduction

Oral epithelial dysplasia (OED) is defined as a lesion in which part of the thickness of the epithelium is replaced by cells showing varying degrees of cellular atypia and maturational disturbances.1 Various attempts have been made to classify OED. On 2005, WHO, propose classification system which divides OED into mild, moderate, severe dysplasia and carcinoma in situ based on assessment for the presence of various architectural and cytologic changes identified on light microscopy.1 A 2-tier system has been developed more recently by Kujan et al.2 which categorizes OED into low and high risk of undergoing malignant transformation, in an attempt to make histopathology more practical for the clinician. However, the use of histopathology for the diagnosis and categorization of OED has long been considered contraversal, with poor inter- and intraobserver agreement and low levels of reproducibility,3 and there is currently no consensus regarding risk of malignant transformation based on histopathology.4

Dysplasia within the oral mucosa can be potentially malignant, ultimately giving rise to oral squamous cell carcinoma. Lesions with features of severe oral epithelial dysplasia (OED) and carcinoma-in-situ are particularly liable to become frank malignancies, and to contain chromosomal anomalies similar to those of oral squamous cell carcinoma.5, 6, 7 However the malignant potential off OED can be variable and unpredictable.8, 9, 10 A wide spectrum of additional markers of malignant transformation, principally based upon immunohistochemical assays have been proposed to aid the diagnosis and determine the prognosis of OED lesions, however in general, these have not proven to be reliable or practical.11, 12, 13 and some researcher indicated that combining DNA ploidy analysis with dysplasia grading will give a higher predictive value than either technique alone.14

Thus until better methods of diagnosis become available there is a need to have a greater understanding of the likely behaviour of lesions with OED. Hence the aim of the present study was to examine the long-term behaviour of a large group of lesions with OED, in particular to determine the rates of malignant change, recurrence and development of new dysplastic disease.

Materials and methods

In this hospital based cross-sectional study, all biopsy reports with histologically confirmed OED between 2012 and 2018 were reviewed retrospectively. Clinical, histopathological and risk factor data were recorded for all patients as identified from histopathological records held in the Oral Surgery department.

Data were collected on a standardized form and loaded into a computer database (SPSS version 20). Recorded data included personal information, history of tobacco smoking and alcohol consumption. Details of tobacco use included type of tobacco, daily amount used (expressed as cigarettes per day), duration of habit and, when applicable, number of years since cessation of smoking. Exclusion criteria were previous oral carcinoma, insufficient sample for analysis, or lack of demographic information to obtain follow up data. 359 patients with OED for whom their was sufficient data to assess long-term outcomes were included in the study. Patients were followed up for period of 2–274 months with a mean follow-up time of up to 40 months. Malignant transformation was considered if a histopathologically proven oral squamous cell carcinoma (SCC) arose in the lesion which had histopathological evidence of OED; recurrence of a dysplastic lesion was considered if a second histopathologically proven dysplastic lesion developed at the same site during follow-up while second dysplastic lesions were considered when a new histopathologically proven OED lesion developed at a site different to that of the index dysplastic lesion.

Statistical analysis

The chi-square and Fisher's exact tests were used for statistical analysis of the results with p value considered significant if less than 0.05.

Results

Twenty (5.5%) of the 359 patients developed a SCC of the oral mucosa over a period of 2–274 months with mean transformation time of 3.3 years. Nine of the patients with SCC (45.0%) were male and 11 (55.0%) female. The mean age at time of diagnosis of SCC was 52.6 years with range of (15–84 years). The mean age for males was 57.1 years (range 44–81 years), the mean age for females 49.0 (range 15–84 years). Eleven of the 20 SCC developed in patients older than 50 years (Table 1).

Table 1.

Demographic characteristics of 20 patients who developed a squamous cell carcinoma subsequent to oral epithelial dysplasia compared with patients who did not develop malignancy.

Variables OED with later SCC
OED with no SCC
No % No %
Age (years)
 < 40 2 10.0 50 14.7
 40-50 7 35.0 79 23.3
 > 50 11 55.0 210 61.9
 Total 20 100.0 339 100.0
Gender
 Male 9 45.0 181 53.3
 Female 11 55.0 158 46.6
 Total 20 100.0 339 100.0
Ethnic-background
Caucasian 15 75.0 204 60.1
Indian 2 10.0 21 6.1
Pakistani and Bangladeshi 3 15.0 47 13.8
Afro-caribbeans 4 1.1
Others 63 18.5
Total 20 100.0 339 100.0
Marital status
 Married 8 40.0 142 53.9
 Single 4 20.0 48 18.2
 Widowed 4 20.0 32 12.1
 Divorced 4 20.0 41 15.5
 Total 20 100.0 263 100.0

OED= Oral epithelial dysplasia.

SCC= Squamous cell carcinoma.

Nine of the 20 SCC (45%) developed from mixed lesions (erythro-leukoplakia), 4 (20.0%) from white lesions, 6 (30.0%) from red lesions and one (5.0%) from an area of ulceration (Table 2). The floor of mouth (40.0%) was the most common site of malignant changes. But of note a significant number of gingival lesions transformed to invasive cancer (P < 0.01). Malignant transformation was uncommon on the dorsal surface of tongue, alveolar ridge and retromolar area (Table 3). Malignant transformation was more likely with lesions already having features of moderate or severe OED (Table 4). Three (15%) of the 20 oral SCCs developed from areas of dysplastic lesions that had previously been surgically excised. However, a significant number (P=0.001) of malignancies developed in lesions treated only with topical antifungal agents (nystatin or amphotericin). Five (25%) of the 20 tumours developed in patients who had only been advised to reduce their tobacco smoking and alcohol drinking (Table 5), their exact compliance with this advice was not known. Sixty-three (17.5%) of the 359 patients had a recurrence of OED and 37 (10.3%) developed additional dysplastic lesions. The majority of these patients were over 50 years of age, there was a slight male predominance in those who had a recurrence of OED but slightly more females than males developed additional dysplastic lesions but the differences were not statistically significant (Table 6).

Table 2.

Clinical type of oral epithelial dysplasia (OED) and subsequent development of squamous cell carcinoma (SCC).


Clinical type of the lesion
OED with later SCC
OED with no SCC
No % No % P value
White patch 4 20.0 166 48.9 0.09
Mixed (white and red) 9 45.0 150 44.2 0.9
Red patch 6 30.0 3 0.8 0.001
Ulcer 1 5.0 17 5.0 0.7
Lump 3 0.8
Total 20 100.0 339 100.0

P for chi-square test.

OED=Oral epithelial dysplasia.

SCC=Squamous cell carcinoma.

Table 3.

Distribution according to site of oral epithelial dysplasia (OED) and subsequent development of squamous cell carcinoma (SCC).


Site
OED with later SCC
OED with no SCC
No % No % P value
Floor of mouth 8 40.0 59 17.4 0.01
Gingiva 3 15.0 8 2.3 0.003
Soft palate 3 15.0 20 5.8 0.1
Buccal mucosa 2 10.0 68 20.0 0.2
Lateral border of tongue 2 10.0 21 6.1 0.5
Ventral border of tongue 1 5.0 56 16.5 0.1
Labial mucosa 1 5.0 38 11.2 0.3
Dorsal surface of tongue 23 6.7
Alveolar ridge 19 5.6
Retro-molar area 25 7.3
Commissure 2 0.5
Total 20 100.0 339 100.0

P for chi-square test.

OED=Oral epithelial dysplasia.

SCC=Squamous cell carcinoma.

Table 4.

Histology of oral epithelial dysplasia (OED) and subsequent development of squamous cell carcinoma (SCC).


Degree of dysplasia
OED with later SCC
OED with no SCC
No % No % P value
Mild dysplasiaa 3 15.0 164 48.3 0.004
Moderate dysplasiab 4 20.0 100 29.4 0.3
Severe dysplasiac 11 55.0 75 22.1 0.001
Carcinoma in-situ 2 10.0
Total 20 100.0 339 100.0

OED=Oral epithelial dysplasia.

SCC=Squamous cell carcinoma.

a

Chi-square = 3.88.

b

Chi-square = 0.44.

c

Chi-square = 5.57.

Table 5.

Treatment method of oral epithelial dysplasia (OED) and subsequent development of squamous cell carcinoma (SCC).


Treatment methods
OED with later SCC
OED with no SCC
No % No % P value
Surgical excisiona 3 15.0 207 61.0 0.0001
Antifungal drugsb 12 60.0 52 15.3 0.001
Advice to moderate alcohol and tobacco habitsc 5 25.0 80 23.5 0.8
Total 20 100.0 339 100.0

OED=Oral epithelial dysplasia.

SCC=Squamous cell carcinoma.

a

Chi-square = 5.85.

b

Chi-square = 13.4.

c

Chi-square = 4.32.

Table 6.

Demographic characteristics of patients showing recurrence or additional oral epithelial dysplastic lesions.


Variables
Recurrence (no = 63)
Second dysplastic lesions (no = 37)
No % No %
Age (years)
 <40 4 6.3 2 5.4
 40–50 16 25.3 10 27.0
 >50 43 68.2 25 67.5
 Total 63 100.0 37 100.0
Gender
 Male 37 58.7 17 46.0
 Female 26 41.2 20 54.0
 Total 63 100.0 37 100.0

Recurrence of OED was most commonly associated with (erythroleukoplakias) lesions in contrast to second dysplastic lesions which usually arose in patients with an initial lesions having the appearance of (leukoplakia) (Table 7). The tongue, buccal mucosa and floor of mouth were the most common sites of recurrent or second OED lesions. Patients treated surgically and/or with antifungals were at greater risk of showing recurrence or additional dysplasia. Cessation of tobacco smoking and alcohol drinking habits associated with a decreased risk of recurrence of OED (P < 0.006) (Table 8).

Table 7.

Clinical and histological aspects of oral epithelial dysplasia lesions that recurred or developed second lesions.


Variables
Recurrence of OED (no = 63)
Second OED lesion (no = 37)
No % No %
Clinical type
 White patch 18 28.5 21 56.7
 Red patch 9 14.2 5 13.5
 Mixed 36 57.1 11 29.7
Site of lesion
 Labial mucosa 6 9.5 2 5.4
 Tongue 20 31.7 11 29.7
 Gingivaa 2 3.1 2 5.4
 Floor of mouth 11 17.4 9 24.3
 Buccal mucosa 13 20.6 7 18.9
 Other sitesb 11 17.4 6 16.2
Histologye
 Mild 10 16.9 7 18.9
 Moderate 16 27.1 14 37.8
 Severe 33 55.9 16 43.2
Treatment method
Surgical excision 16 25.3 20 54.0
Cryosurgery 12 19.0 5 13.5
Laser excision 8 12.6 3 8.1
PDTc 2 3.1
Antifungal therapy 16 25.3 8 21.6
No active treatment° 9 14.2 1 d.7

OED = oral epithelial dysplasia.

a

Gingiva and alveolar ridge combined.

b

Other sites include soft palate, retromolar area.

c

Photodynamic therapy.

d

Patients advised to stop smoking and drinking.

e

Histology only known for 59 cases.

Table 8.

Tobacco and alcohol habits of patient with recurrence or second oral epithelial dysplasia lesions (OED) at last clinical appointment.

Recurrence of OED
Second OED lesion
No % No %
Stop smoking and 'drinking 9# 15.2 6ϕ 16.2
Reduce smoking and drinking 22 37.2 12 32.4
No change of habits 28# 47.4 19ϕ 51.3
Total 59 100.0 37 100.0

OED= Oral epithelial dysplasia.

#p < 0.006.

ϕp < 0.02.

Discussion

Oral epithelial dysplasia characterized by a spectrum of architectural and cytological alterations caused by accumulation of genetic changes, and is associated with the use of tobacco and alcohol.11, 12, 13, 14, 15 The histopathological diagnosis of OED can be difficult, particularly as there is a need to determine the degree of dysplastic change.16,17 Examination of the sequentially excised specimens may reveal a range of grades of dysplasia in various portions of the same OED specimen, suggesting that incisional biopsy samples may not be representative of the true nature of the lesion and histologic examination of the entire clinical lesion may be necessary for accurate grading of dysplastic lesions.6,17 However it is sometimes practically difficult and/or unjustifiable to excise entire lesions without some knowledge of its pathology, and the clinical appearance may not mirror the histopathological features.18

Several studies have been published on the biological behaviour of OED.5,6,8, 9, 10,18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32 The transformation rates varied between 5% and 36%, and it is evident that 460 (9.21%) of 4992 observed patients developed invasive squamous cell carcinomas within follow-up periods of 20 years (Table 9).

Table 9.

Summary of published cases of oral epithelial dysplasia (OED) that transformed to invasive squamous cell carcinoma.

Authors Year No Number of invasive SCC Transformation time (yr.) Transformation rate %
Mincer et al.8 1972 45 5 up to 8 11
Banoczy & Csiba18 1976 68 9 1-20 Mean 6.3 13.2
Pindborg et al.9 1977 61 4 up to 7 6.6
Gupta et al.10 1980 73 6 10 Mean 8.5 8.2
Silverman et al.5 1984 22 8 Mean 8.1 36.4
Vedtofte et al.19 1987 47 3 Mean 3.9 6.3
Cregg and Cowan20 1992 135 24 15 years 17.7
Lumerman et al.6 1995 44 7 up to 6.5 16
Cowan et al.21 2001 165 24 4 years 15
Hsue et al.22 2007 166 8 10 years 5
Arduino et al.23 2009 207 15 16 years 7
Ho et al.24 2009 33 8 Mean 3 years 24
Bradley et al.25 2010 1434 139 9.7
Warnakulasuriya et al.26 2011 104 5 10 years 5
Liu et al.27 2011 138 37 5.1 years 26.8
Ho et al.28 2013 91 23 4 years 25
Sperandio et al.29 2013 201 17 8.5
Brouns et al.30 2014 88 8 15 years 9
Dost et al.31 2014 368 18 3.3 years 4.7
Wang et al.32 2014 1143 72 2.8 years 6.30
Present study 2019 359 20 3.3 years 5.5
Total 4992 460 Up to 20 years 9.21

OED= Oral epithelial dysplasia.

SCC= Squamous Cell Carcinoma.

In the present study 5.5% of patients with OED diagnosed histopathologically from incisional biopsies developed a subsequent SCC within 2–274 months after initial diagnosis, with a mean time to malignant transformation of 40 months. This frequency of development of malignancy is less than that of the other comparable studies.5,6,8,9,20, 21, 22,24, 25, 26,28, 29, 30, 31, 32 (see Table 9). One explanation for this difference might be that the majority of our patient had mild OED, which reported to have a lower risk of malignant transformation potential.28,29

In the present study oral SCC tended to develop in patients who had had previous severe OED, however, malignancy also arose in patients who had had mild or moderate OED. Hence, like previous studies the degree of dysplasia within lesions may itself alone not be a reliable predictor of prognosis.12,13,24,33,34

The clinical appearance of lesions was not a helpful predictor of the degree of dysplasia present and the malignant potential of a lesion. Previous studies have suggested certain morphological characteristics are associated with the risk of malignant transformation of OED.35,36 In this study 45.0% of malignancies arose from areas of erythroleukoplakic lesions and 30.0% from red lesions a findings similar to the observations of Amagasa.34 Hence, while oral malignancy may arise from areas of pre-existing leukoplakia (known to have OED), it seems that malignancy is more likely to arise in lesions with areas of redness. The site of pre-existing OED has been suggested to influence malignant changes. For example the floor of mouth has been reported to be a possible risk site for malignant transformation.36,37 In the present study the floor of mouth was among the most common sites of malignant transformation and does suggest that clinicians would be advised to consider all longstanding, solitary, non-traumatic lesions in this site as being potentially malignant until proven otherwise. The increased risk of malignant change at this site is further highlighted by report of high rates of loss of heterozygosity on chromosomes 3p, 9p and 17p in oral leukoplakias of the floor of mouth compared with other oral mucosal sites – even when corrected for degree of histopathologically-determined dysplasia.38

Malignant transformation occurred in patients who received different treatment for their OED lesions. Although the rate of malignant transformation was less for lesions that had been surgically excised than managed by non-surgical methods, oral SCC still developed in sites of previously excised OED. The rate of recurrence of OED was lower for lesions treated surgically than those managed non-surgically, hence despite the possible risk of disease as observed in this and other studies.5,19 and the absence of any reliable and/or safe non-surgical therapy,39,40 and excision of OED lesions remains the first, and possible only treatment of such disease.19 Recurrence and/or malignant transformation may reflect difficulties in determining the margin of lesions, particularly those on the floor of mouth where dysplastic involvement of the salivary gland ducts may not be detected clinically.41, 42, 43

Most patients did not change their tobacco smoking or alcohol drinking habits after treatment - only 15.2% of patients stopping smoking and drinking before development of recurrence of OED, and 16.2% before development of additional OED lesions. These factors were significant in this study with risk of recurrence and development of second OED significantly different between those who stopped these habits and those who continue these habits which indicated the need to encourage all patients to modify there habits when dysplastic lesions were diagnosed and treated. Chiesa and colleagues44 found modification of these habits is not significant predictor for development of relapses in operated oral leukoplakia while others found that cancer and other changes developed more frequently in those patients with leukoplakia who did not stop smoking and drinking.45 It is also reported that leukoplakia may disappear if patients stop smoking.5,33,46

The results of the present study indicate that OED does not invariably progress to carcinoma although it can be difficult to predict precisely the long term behaviour of such disease, particularly when there is moderate dysplasia. Clinical examination together with histopathological evaluation of incisional biopy material does not allow accurate assessment of long term outcome of OED lesions, in addition despite surgical excision, recurrence and/or malignant transformation can still occur (Table 10). There is thus a need for sensitive methods that not only identify dysplasia, but also indicate likely prognosis. Aside from loss of heterozygosity38 it has been suggested that ploidy may be a reliable prognostic marker of oral leukoplakia and OED.47 Vital staining with tolonium chloride does not reliably detect mild or moderate OED48 and while cytological examination of brush biopsies may provide the clinician with a non-invasive and rapid method of detecting OED it does not provide detail of the likely degree of dysplasia, and thus has no prognostic value.49

Table 10.

Follow-up studies on patients with epithelial dysplasia whose lesions were excised.

Authors No of cases Cured Recurred Developed SCC
Mincer et al.8 20 10 (50.0%) 7 (35.0%) 3 (15.0%)
Banoczy et al.18 45 43 (95.5%) 1 (2.2%) 1 (2.2%)
Vedtofte et al.19 61 46 (75.4%) 12 (19.6%) 3 (5.0%)
Total 126 99 (78.5%) 20 (15.8%) 7 (5.5%)

SCC=Squamous cell carcinoma.

It is concluded that while the risk of malignant transformation of OED may be approximately 5% there is a need to develop effective methods of predicting long term outcomes of such disease.

Declaration of Competing Interest

The authors have no conflicts of interest relevant to this article.

Acknowledgements

None.

References

  • 1.Barnes L., Eveson J., Reichart P., Sidransky D., editors. World Health Organization classification of tumors: Pathology and Genetics of Head and neck tumors. IARC Press; Lyon, France: 2005. [Google Scholar]
  • 2.Kujan O., Oliver R., Khattab A., Roberts S., Thakker N., Sloan P. Evaluation of a new binary system of grading oral epithelial dysplasia for prediction of malignant transformation. Oral Oncol. 2006;42:987–993. doi: 10.1016/j.oraloncology.2005.12.014. [DOI] [PubMed] [Google Scholar]
  • 3.Abbey L., Kaugars G., Gunsolley J. Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;80:188–191. doi: 10.1016/s1079-2104(05)80201-x. [DOI] [PubMed] [Google Scholar]
  • 4.Speight P. Update on oral epithelial dysplasia and progression to cancer. Head and Neck Pathol. 2007;1:61–66. doi: 10.1007/s12105-007-0014-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Silverman S., Gorsky M., Lozada F. Oral leukoplakia and malignant transformation: a follow-up study of 257 patients. Cancer. 1984;53:563–568. doi: 10.1002/1097-0142(19840201)53:3<563::aid-cncr2820530332>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  • 6.Lumerman H., Freedman P., Kerpel S. Oral epithelial dysplasia and the development of invasive squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;97:321–329. doi: 10.1016/s1079-2104(05)80226-4. [DOI] [PubMed] [Google Scholar]
  • 7.Ostor A. Natural history of cervical intraepithelial neoplasia: a critical Review. Int J Gynaecol Pathol. 1993;12:186–192. [PubMed] [Google Scholar]
  • 8.Mincer H., Coleman S., Hopkins K. Observation on the clinical characteristics of oral lesions showing histologic epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1972;33:389–399. doi: 10.1016/0030-4220(72)90468-9. [DOI] [PubMed] [Google Scholar]
  • 9.Pindborg J., Daftary D., Mehta F. A follow-up study of sixty-one oral dysplastic precancerous lesions in Indian villagers. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1977;43:383–390. doi: 10.1016/0030-4220(77)90325-5. [DOI] [PubMed] [Google Scholar]
  • 10.Gupta P., Mehta F., Daftary D. Incidence rates of oral cancer and natural history of oral precancerous lesions in a 10-year follow-up study of Indian villagers. Community Dent Oral Epidemiol. 1980;8:325–326. doi: 10.1111/j.1600-0528.1980.tb01302.x. [DOI] [PubMed] [Google Scholar]
  • 11.Kashiwazaki H., Tonoki H., Tada M. High frequency of p53 mutations in human oral epithelial dysplasia and primary squamous cell carcinoma detected by yeast functional assay. Oncogene. 1997;15:2667–2674. doi: 10.1038/sj.onc.1201438. [DOI] [PubMed] [Google Scholar]
  • 12.Pitiyage G., Tilakaratne W., Tavassoli M., Warnakulasuriya S. Molecular markers in oral epithelial dysplasia: review. J Oral Pathol Med. 2009;38:737–752. doi: 10.1111/j.1600-0714.2009.00804.x. [DOI] [PubMed] [Google Scholar]
  • 13.Lingen M., Pinto A., Mendes R. Genetics epigenetics of oral premalignancy: current status and future research. Oral Dis. 2011;17:7–22. doi: 10.1111/j.1601-0825.2011.01789.x. [DOI] [PubMed] [Google Scholar]
  • 14.Kalen R., Warnakulasuriya S., Rosnah Z., Sok C. Potentially malignant disorders of the oral cavity: current practice and future directions in the clinic and laboratory. Int J Canc. 2015;136:503–515. doi: 10.1002/ijc.28754. [DOI] [PubMed] [Google Scholar]
  • 15.Jaber M., Porter S., Scully C., Gilthrope M., Bedi R. Risk factors for oral epithelial dysplasia- the role of smoking and alcohol. Oral Oncol. 1999;35:151–156. doi: 10.1016/s1368-8375(98)00106-7. [DOI] [PubMed] [Google Scholar]
  • 16.Pindborg J., Reibel J., Holmstrup P. Subjectivity in evaluating oral epithelial dysplasia, carcinoma in situ and initial carcinoma. J Oral Pathol Med. 1985;14:698–708. doi: 10.1111/j.1600-0714.1985.tb00549.x. [DOI] [PubMed] [Google Scholar]
  • 17.Wright A., Shear M. Epithelial dysplasia immediately adjacent to oral squamous cell carcinoma. J Oral Pathol Med. 1985;14:559–564. doi: 10.1111/j.1600-0714.1985.tb00529.x. [DOI] [PubMed] [Google Scholar]
  • 18.Banoczy J., Csiba A. Occurrence of epithelial dysplasia in oral leukoplakia: analysis and follow up study of 120 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1976;42:766–774. doi: 10.1016/0030-4220(76)90099-2. [DOI] [PubMed] [Google Scholar]
  • 19.Vedtofte P., Holmstrup P., Horting-Hanson E., Pindborg J. Surgical treatment of premalignant lesions of the oral mucosa. Int J Oral Maxillofac Surg. 1987;16:656–664. doi: 10.1016/s0901-5027(87)80049-8. [DOI] [PubMed] [Google Scholar]
  • 20.Gregg T., Cowan C. Trends in the relative frequencey of histologically diagnosed epithelial dysplasia and intra-oral carcinoma in Northern Ireland 1975-1989. Br Dent J. 1992;173:234–236. doi: 10.1038/sj.bdj.4808006. [DOI] [PubMed] [Google Scholar]
  • 21.Cowan C., Gregg T., Napier S., McKenna S., Kenna F. Potentially malignant oral lesions in Northern Ireland: a 20-year population-based perspective of malignant transformation. Oral Dis. 2001;7:18–24. [PubMed] [Google Scholar]
  • 22.Hsue S., Wang W., Chen C., Lin C., Chen Y., Lin L. Malignant transformation in 1458 patients with potentially malignant oral mucosal disorders: a follow-up study based in a Taiwanese hospital. J Oral Pathol Med. 2007;36:25–29. doi: 10.1111/j.1600-0714.2006.00491.x. [DOI] [PubMed] [Google Scholar]
  • 23.Arduino P., Surace A., Carbone M. Outcome of oral dysplasia: a retrospective hospital-based study of 207 patients with a long follow-up. J Oral Pathol Med. 2009;38:540–544. doi: 10.1111/j.1600-0714.2009.00782.x. [DOI] [PubMed] [Google Scholar]
  • 24.Ho P., Chen P., Warnakulasuriya S., Shieh T., Chen Y., Huang I. Malignant transformation of oral potentially malignant disorders in males: a retrospective cohort study. BMC Canc. 2009;9:260. doi: 10.1186/1471-2407-9-260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Bradley G., Odell E., Raphael S. Abnormal DNA content in oral epithelial dysplasia is associated with increased risk of progression to carcinoma. Br J Canc. 2010;103:1432–1442. doi: 10.1038/sj.bjc.6605905. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Warnakulasuriya S., Kovacevic T., Madden P. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England. J Oral Pathol Med. 2011;40:677–683. doi: 10.1111/j.1600-0714.2011.01054.x. [DOI] [PubMed] [Google Scholar]
  • 27.Liu W., Bao Z., Shi L., Tang G., Zhou Z. Malignant transformation of oral epithelial dysplasia: clinicopathological risk factors and outcome analysis in a retrospective cohort of 138 cases. Histopathology. 2011;59:733–740. doi: 10.1111/j.1365-2559.2011.03938.x. [DOI] [PubMed] [Google Scholar]
  • 28.Ho M., Field E., Field J. Outcomes of oral squamous cell carcinoma arising from oral epithelial dysplasia: rationale for monitoring premalignant oral lesions in a multidisciplinary clinic. Br J Oral Maxillofac Surg. 2013;51:594–599. doi: 10.1016/j.bjoms.2013.03.014. [DOI] [PubMed] [Google Scholar]
  • 29.Sperandio M., Brown A., Lock C. Predictive value of dysplasia grading and DNA ploidy in malignant transformation of oral potentially malignant disorders. Canc Prev Res. 2013;6:822–831. doi: 10.1158/1940-6207.CAPR-13-0001. [DOI] [PubMed] [Google Scholar]
  • 30.Brouns E., Baart J., Karagozoglu K. Malignant transformation of oral leukoplakia in a well-defined cohort of 144 patients. Oral Dis. 2014;20:19–24. doi: 10.1111/odi.12095. [DOI] [PubMed] [Google Scholar]
  • 31.Dost F., Le K., Ford P. Malignant transformation of oral epithelial dysplasia: a real-world evaluation of histopathologic grading. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2014;117:343–352. doi: 10.1016/j.oooo.2013.09.017. [DOI] [PubMed] [Google Scholar]
  • 32.Wang Y., Tail Y., Wang W. Malignant transformation in 5071 southern Taiwanese patients with potentially malignant oral mucosal disorders. BMC Oral Health. 2014;14:99. doi: 10.1186/1472-6831-14-99. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Lind P. Malignant transformation in oral leukoplakia. Scand J Dent Res. 1987;95:449–455. doi: 10.1111/j.1600-0722.1987.tb01959.x. [DOI] [PubMed] [Google Scholar]
  • 34.Amagasa T., Yokooe E., Sato K. A study of the clinical characteristics and treatment of oral carcinoma in-situ. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1985;60:50–55. doi: 10.1016/0030-4220(85)90215-4. [DOI] [PubMed] [Google Scholar]
  • 35.Shibuya H., Amagasa T., Seto K., Ishibashi K., Horiuchi J. Leukoplakia associated multiple carcinomas in patients with tongue carcinoma. Cancer. 1986;57:843–846. doi: 10.1002/1097-0142(19860215)57:4<843::aid-cncr2820570426>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  • 36.Kramer I., El-Labban N., Lee K. The clinical features and risk of malignant transformation in sublingual keratosis. Br Dent J. 1978;144:171–180. doi: 10.1038/sj.bdj.4804055. [DOI] [PubMed] [Google Scholar]
  • 37.Pogrel M. Sublingual keratosis and malignant transformation. J Oral Pathol Med. 1979;8:176–178. doi: 10.1111/j.1600-0714.1979.tb01824.x. [DOI] [PubMed] [Google Scholar]
  • 38.Zhang L., Cheung KJr, Lam W. Increased genetic damage in oral leukoplakia from high risk sites: potential impact on staging and clinical management. Cancer. 2001;91:2148–2155. doi: 10.1002/1097-0142(20010601)91:11<2148::aid-cncr1243>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  • 39.Hong W., Endicott J., ltri L. 13-cis-Retinoic acid in the treatment of oral leukoplakia. N Engl J Med. 1986;35:1501–1505. doi: 10.1056/NEJM198612113152401. [DOI] [PubMed] [Google Scholar]
  • 40.Lippman S., Batsakis J., Toth B. Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. N Engl J Med. 1993;328:15–20. doi: 10.1056/NEJM199301073280103. [DOI] [PubMed] [Google Scholar]
  • 41.Chiesa F., Costa L., Moglia D. Excision of oral leukoplakia bu CO2 laser on an out-patient basis:a useful procedure for prevention and early detection of oral carcinoma. Tumori. 1986;72:307–312. doi: 10.1177/030089168607200312. [DOI] [PubMed] [Google Scholar]
  • 42.Browne R., Potts A. Dysplasia in salivary gland ducts in sublingual leukoplakia and erythroplakia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1986;82:44–48. doi: 10.1016/0030-4220(86)90068-x. [DOI] [PubMed] [Google Scholar]
  • 43.Daley T., Lovas J., Peters E., Wysocki G., McGaw T. Salivary gland ductal involvement in oral epithelial dysplasia and squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996;81:186–192. doi: 10.1016/s1079-2104(96)80413-6. [DOI] [PubMed] [Google Scholar]
  • 44.Chiesa F., Boracchi P., Tradati N. Risk of preneoplastic and neoplastic events in operated oral leukoplakias. Oral Oncol. 1993;29B:23–28. doi: 10.1016/0964-1955(93)90006-z. [DOI] [PubMed] [Google Scholar]
  • 45.Banoczy R. Follow-up studies in oral leukoplakia. J Oral Maxillofac Surg. 1977;5:69–75. doi: 10.1016/s0301-0503(77)80079-9. [DOI] [PubMed] [Google Scholar]
  • 46.WHO, Collaborative centre for oral precancerous lesions Defination of leukoplakia and related lesions: an aid to studies in oral precancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1978;46:518–539. [PubMed] [Google Scholar]
  • 47.Bremmera J., Brakenhoff R., Broeckaert M. Prognostic value of DNA ploidy status in patients with oral leukoplakia. Oral Oncol. 2011;47:956–960. doi: 10.1016/j.oraloncology.2011.07.025. [DOI] [PubMed] [Google Scholar]
  • 48.Onofre M., Sposto M., Navarro C., Motta M., Turatti E., Almeida R. Potentially malignant epithelial oral lesions: discrepancies between clinical and histological diagnosis. Oral Dis. 1997;3:148–152. doi: 10.1111/j.1601-0825.1997.tb00026.x. [DOI] [PubMed] [Google Scholar]
  • 49.Sciubba J. Oral cancer. The importance of early diagnosis and treatment. Am J Clin Dermatol. 2001;2:239–251. doi: 10.2165/00128071-200102040-00005. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Dental Sciences are provided here courtesy of Association for Dental Sciences of the Republic of China

RESOURCES